Table 3. MRI protocol for ARIA.
| Component | MRI protocol |
|---|---|
| Scanner field strength | 1.5T (minimum) or 3T (recommended) |
| Slice thickness | ≤5 mm |
| Echo time | ≥20 ms |
| Scan time | ≤15 min (recommended) |
| Imaging sequence | T2-FLAIR (2D or 3D): For ARIA-E (vasogenic edema in the parenchyma, effusion and exudate in the leptomeninges) |
| T2* GRE (or SWI)*: For ARIA-H (microhemorrhage in the parenchyma, superficial siderosis in the leptomeninges) | |
| Diffusion-weighted imaging: For the differential diagnosis of cytotoxic edema including acute infarction | |
| 3D T1-imaging (optional): For the assessment of brain atrophy and disease progression |
*The sequence of the baseline and follow up monitoring MRI (T2* GRE or SWI) should be consistent and matching.
ARIA = amyloid-related imaging abnormalities, D = dimensional, GRE = gradient echo, SWI = susceptibility-weighted imaging